Lemaître S, Lecler A, Lévy-Gabriel C, Reyes C, Desjardins L, Gentien D, Zmuda M, Jacomet P V, Lumbroso-Le Rouic L, Dendale R, Vincent-Salomon A, Pierron G, Galatoire O, Cassoux N
Institut Curie, 26, rue d'Ulm, 75005 Paris, France; Université Paris Descartes, 12, rue de l'École-de-Médecine, 75270 Paris cedex 06, France.
Fondation ophtalmologique Adolphe de Rothschild, 25-29, rue Manin, 75019 Paris, France.
J Fr Ophtalmol. 2017 Feb;40(2):93-101. doi: 10.1016/j.jfo.2016.10.007. Epub 2017 Jan 23.
Evisceration can be performed for blind, painful eyes. This surgery can promote the dissemination of tumor cells within the orbit if an ocular tumor has been missed preoperatively.
We reviewed the medical records of patients who were eviscerated for blind, painful eyes between 2009 and 2014 and who were referred after the surgery to the Institut Curie or the Rothschild Foundation in Paris. We included the patients with a histological diagnosis of ocular tumor or orbital recurrence. Cytogenetic analysis was performed whenever possible.
Four patients turned out to have an ocular tumor after evisceration (two choroidal melanomas, a rhabdoid tumor and an adenocarcinoma of the retinal pigment epithelium); two had a history of prior ocular trauma. The tumors were diagnosed either on histological analysis of the intraocular contents (2 patients) or biopsy of orbital recurrence (2 patients). Prior to evisceration, fundus examination was not performed in 3 patients. One had preoperative imaging but no intraocular tumor was suspected. At the time of this study, 3 patients had had an orbital recurrence and died. We also found 2 patients who had an evisceration despite a past history of choroidal melanoma treated with proton beam therapy.
We showed that evisceration of eyes with unsuspected ocular malignancies was associated with a poor prognosis due to orbital recurrence and metastasis. The evisceration specimen should therefore always be sent for histological analysis in order to perform prompt adjuvant orbital radiotherapy if an ocular tumor is found.
眼球摘除术可用于失明且疼痛的眼睛。如果术前漏诊眼内肿瘤,该手术会促进肿瘤细胞在眼眶内扩散。
我们回顾了2009年至2014年间因失明且疼痛的眼睛而接受眼球摘除术、术后转诊至巴黎居里研究所或罗斯柴尔德基金会的患者的病历。我们纳入了经组织学诊断为眼内肿瘤或眼眶复发的患者。尽可能进行细胞遗传学分析。
4例患者在眼球摘除术后被发现患有眼内肿瘤(2例脉络膜黑色素瘤、1例横纹肌样瘤和1例视网膜色素上皮腺癌);2例有眼部外伤史。肿瘤通过眼内容物的组织学分析(2例患者)或眼眶复发活检(2例患者)得以诊断。在眼球摘除术前,3例患者未进行眼底检查。1例患者术前行影像学检查,但未怀疑眼内肿瘤。在本研究时,3例患者出现眼眶复发并死亡。我们还发现2例尽管过去曾接受质子束治疗脉络膜黑色素瘤但仍接受了眼球摘除术的患者。
我们表明,对未怀疑有眼内恶性肿瘤的眼睛进行眼球摘除术,由于眼眶复发和转移,预后较差。因此,眼球摘除标本应始终送检进行组织学分析,以便在发现眼内肿瘤时及时进行辅助性眼眶放疗。